Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

GPX4 (R)-9i is a ferroptosis inducer.1 It binds to GPX4 in a cellular thermal shift assay (CETSA) using HT-1080 fibrosarcoma cells (Kd = 20.4 nM) and inhibits GPX4 activity in a cell-free assay. It is cytotoxic to HT-1080 cells, an effect that can be reversed by the ferroptosis inhibitor ferrostatin-1 (IC50s = 0.3 and 7,482 nM, respectively). The cytotoxicity of GPX4 (R)-9i to HT-1080 cells is not reversed by the addition of Z-VAD-FMK, indicating selectivity for ferroptosis over apoptosis. It is also cytotoxic to HepG2 hepatocellular carcinoma, MCF-7 breast cancer, CAL 27 oral cancer, and 4T1 murine mammary cancer cells (IC50s = 56, 452, 2,682, and 89 nM, respectively). GPX4 (R)-9i (15 and 30 mg/kg) reduces tumor growth in an HT-1080 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Development of a highly selective ferroptosis inducer targeting GPX4 with 2-